Recruiting
Phase 1

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT03295227

Conditions

Stage III Thymoma AJCC v8

Stage IIIA Thymoma AJCC v8

Stage IIIB Thymoma AJCC v8

Stage IV Thymoma AJCC v8

Stage IVA Thymoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information